Madrigal Pharmaceuticals, Inc. (MDGL)
NASDAQ · Healthcare
Madrigal Pharmaceuticals, Inc. EPS 2012–2025
Madrigal Pharmaceuticals, Inc. annual/quarterly eps history and growth rate from 2020 to 2026. Earnings per share (EPS) is a company's net profit divided by the number of diluted shares outstanding. Higher EPS generally indicates greater profitability.
- Madrigal Pharmaceuticals, Inc. eps for the quarter ending March 31, 2026 was $3.25, a 24.52% increase year-over-year.
- Madrigal Pharmaceuticals, Inc. annual eps for 2025 was $12.85, a 41.32% decrease from 2024.
- Madrigal Pharmaceuticals, Inc. annual eps for 2024 was $21.90, a 9.55% increase from 2023.
- Madrigal Pharmaceuticals, Inc. annual eps for 2023 was $19.99, a 16.02% increase from 2022.
- Madrigal Pharmaceuticals, Inc. annual eps for 2022 was $17.23.
EPS
QUARTERLY · USD
YEAR-OVER-YEAR GROWTH · %
Madrigal Pharmaceuticals, Inc. EPS — FAQ
Madrigal Pharmaceuticals, Inc. (MDGL) eps over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
What is Madrigal Pharmaceuticals, Inc.'s eps?
Madrigal Pharmaceuticals, Inc. (MDGL) reported eps of $-12.85 for fiscal 2025.
Where can I see MDGL's eps history?
The chart and table above show Madrigal Pharmaceuticals, Inc.'s eps by year and by quarter, including the growth rate.